根治性切除治疗胰头癌的手术体会

目的 总结提高胰头癌手术根治率和降低术后并发症发生率的经验。方法 回顾性分析我院1996年1月至2005年3月期间的55例胰头癌根治术患者的临床资料。结果 本组55例胰头癌根治性切除术患者中男31例，女24例，均为胰腺导管癌。2002年前、后根治率分别为25．9％（29／112）和34．7％（26／75），并发症发生率分别为48．3％（14／29）和19．2％（5／26）。提高根治性手术技巧包括胰周淋巴结及神经丛清扫、联合血管切除、综合无血术野技术等。结论 提高胰头癌手术根治率和降低术后并发症发生率有赖于对胰头癌病理生理特点的深入了解和手术技巧的成熟。     

二氢青蒿素对胰腺癌生长的抑制作用

Objective To investigate the anti-tumor activity of dihydroartemisinin in pancreatic cancer in vitro and in vivo. Methods For cultured cells,cell growth was determined by the MTT assay and apoptosis was evaluated by flow cytometry analysis stained with Annexin V-FITG/PI. The protein expression in BxPC-3 cells was analyzed by Western blot assay. BxPC-3 cells were injected subcutaneously into nude mice to establish pancreatic xenograft tumors and the tumor volume was monitored after exposure to dihydroartemisinin. Ki-67 staining and TUNEL assay were used to assess tumor cell proliferation and apoptosis in tumor tissue. Results After treatment by dihydroartemisinin in vitro, the proliferative inhibition rates of pancreatic cancer cells BxPC-3 and AsPC-1 reached up to (76.2 ± 3.5) % and (79.5 ± 2.9) %, and the apoptosis rates were up to (55.5 ± 3.2)% and (40.0 ± 3.5)%, the differences were significantly (P ＜ 0.01) compared with control [(2.0 ± 1.3) % and (0.9 ± 0.4) %]. Dihydroartemisinin inhibited the growth of pancreatic xenograft tumors in nude mice. The proliferation index and apoptusis index were (49.1 ± 3.9)% and (50.2 ± 4.4)% respectively in dihydroarternisinin 50 mg/kg treatment group, compared to those of (72.1 ± 3.3) % and (9.4 ± 2.9) % in control, the differences were significantly (P ＜0.01). Western blot assay indicated that dihydroartemisinin up-regulates expression of proliferation-associated protein p21WAF1 and down-regulates expression of PCNA, increases expression of apoptosis-associated protein Bax and decreases expression of Bcl-2 and activates caspase-9 in BxPC-3 cells. Conclusions Dihydroartemisinin exerts anti-tumor activity in pancreatic cancer both in vitro and in vivo by proliferation inhibition and apoptusis induction. Dihydroartemisinin can be used as a potential anti-tumor drug in pancreatic cancer.     

大黄联合电针促进重症急性胰腺炎胃肠道功能复苏的临床研究

重症急性胰腺炎（SAP）起病凶险、进展迅速、并发症多、预后差、病死率高,常引起全身炎症反应,胃肠道在SAP起病早期首先受累,表现为胃潴留、十二指肠排空迟缓及肠麻痹等症状,如不及时处理,常会导致水电解质紊乱、酸碱失衡,菌群移位、呼吸循环受限、全身感染等严重后果。故胃肠道功能复苏在SAP的早期治疗中具有不可忽视的作用。本研究观察了大黄联合电针对该病的治疗效果,报告如下。     

二氢青蒿素对胰腺癌生长的抑制作用

Objective To investigate the anti-tumor activity of dihydroartemisinin in pancreatic cancer in vitro and in vivo. Methods For cultured cells,cell growth was determined by the MTT assay and apoptosis was evaluated by flow cytometry analysis stained with Annexin V-FITG/PI. The protein expression in BxPC-3 cells was analyzed by Western blot assay. BxPC-3 cells were injected subcutaneously into nude mice to establish pancreatic xenograft tumors and the tumor volume was monitored after exposure to dihydroartemisinin. Ki-67 staining and TUNEL assay were used to assess tumor cell proliferation and apoptosis in tumor tissue. Results After treatment by dihydroartemisinin in vitro, the proliferative inhibition rates of pancreatic cancer cells BxPC-3 and AsPC-1 reached up to (76.2 ± 3.5) % and (79.5 ± 2.9) %, and the apoptosis rates were up to (55.5 ± 3.2)% and (40.0 ± 3.5)%, the differences were significantly (P ＜ 0.01) compared with control [(2.0 ± 1.3) % and (0.9 ± 0.4) %]. Dihydroartemisinin inhibited the growth of pancreatic xenograft tumors in nude mice. The proliferation index and apoptusis index were (49.1 ± 3.9)% and (50.2 ± 4.4)% respectively in dihydroarternisinin 50 mg/kg treatment group, compared to those of (72.1 ± 3.3) % and (9.4 ± 2.9) % in control, the differences were significantly (P ＜0.01). Western blot assay indicated that dihydroartemisinin up-regulates expression of proliferation-associated protein p21WAF1 and down-regulates expression of PCNA, increases expression of apoptosis-associated protein Bax and decreases expression of Bcl-2 and activates caspase-9 in BxPC-3 cells. Conclusions Dihydroartemisinin exerts anti-tumor activity in pancreatic cancer both in vitro and in vivo by proliferation inhibition and apoptusis induction. Dihydroartemisinin can be used as a potential anti-tumor drug in pancreatic cancer.     

胰腺损伤性胰瘘35例临床分析

目的:探讨胰腺损伤性胰痿的防治原则与措施.方法:回顾性分析131例胰腺外伤患者的临床资料,对术后35例并发胰瘘患者行"损伤控制性"手术(damage control surgery,DCS)并实施围手术期综合治疗方案.结果:35例胰瘘患者中3例经引流管造影显示形成内瘘自愈,9例术后形成胰腺假性囊肿行Roux-on-Y囊肿空肠内引流术,2例因MODS、腹腔感染死亡,其余患者均治愈.随访3个月～5年,出院患者无因胰瘘并发症等相关因素死亡者.结论:胰腺损伤性胰瘘的防治需全方位考虑实施DCS及围手术期综合治疗方案,既要有效控制原发损伤,又要积极预防并发症.     

二氢青蒿素对胰腺癌生长的抑制作用

Objective To investigate the anti-tumor activity of dihydroartemisinin in pancreatic cancer in vitro and in vivo. Methods For cultured cells,cell growth was determined by the MTT assay and apoptosis was evaluated by flow cytometry analysis stained with Annexin V-FITG/PI. The protein expression in BxPC-3 cells was analyzed by Western blot assay. BxPC-3 cells were injected subcutaneously into nude mice to establish pancreatic xenograft tumors and the tumor volume was monitored after exposure to dihydroartemisinin. Ki-67 staining and TUNEL assay were used to assess tumor cell proliferation and apoptosis in tumor tissue. Results After treatment by dihydroartemisinin in vitro, the proliferative inhibition rates of pancreatic cancer cells BxPC-3 and AsPC-1 reached up to (76.2 ± 3.5) % and (79.5 ± 2.9) %, and the apoptosis rates were up to (55.5 ± 3.2)% and (40.0 ± 3.5)%, the differences were significantly (P ＜ 0.01) compared with control [(2.0 ± 1.3) % and (0.9 ± 0.4) %]. Dihydroartemisinin inhibited the growth of pancreatic xenograft tumors in nude mice. The proliferation index and apoptusis index were (49.1 ± 3.9)% and (50.2 ± 4.4)% respectively in dihydroarternisinin 50 mg/kg treatment group, compared to those of (72.1 ± 3.3) % and (9.4 ± 2.9) % in control, the differences were significantly (P ＜0.01). Western blot assay indicated that dihydroartemisinin up-regulates expression of proliferation-associated protein p21WAF1 and down-regulates expression of PCNA, increases expression of apoptosis-associated protein Bax and decreases expression of Bcl-2 and activates caspase-9 in BxPC-3 cells. Conclusions Dihydroartemisinin exerts anti-tumor activity in pancreatic cancer both in vitro and in vivo by proliferation inhibition and apoptusis induction. Dihydroartemisinin can be used as a potential anti-tumor drug in pancreatic cancer.     

RASSF1A在胰腺癌组织中的表达及其临床意义

目的 探讨押癌基因RASSF1A在胰腺癌组织中的表达及其与胰腺癌发生、发展的关系.方法 采用逆转录-聚合酶链反应(RT-PCR)方法检测48例胰腺癌组织及癌旁正常组织RASSFA mRNA的表达水平.结果 癌旁正常组织RASSF1A mRNA的表达量高于高分化腺癌组织RASSF1A的表达量,差异有统计学意义(P<0.05).高分化腺癌组织RASSF1A mRNA的表达量高于中低分化腺癌组织,差异有统计学意义(P<0.01).TNM分期Ⅲ期RASSF1A mRNA的表达量低于Ⅰ、Ⅱ期,差异有统计学意义(P<0.05).RASSF1A mRNA表达与性别、年龄,肿瘤发生部位无明显关系(P>0.05).结论 RASSF1A表达缺失或低下在胰腺癌的发生、发展中起重要的作用.     

急性心肌梗死溶栓后并发脑梗死2例

目的：对ST段抬高急性心肌梗死（STAMI）溶栓后并发急性脑梗死发病情况进行探讨。方法：登记我院近4年STAMI患者溶栓后出现急性脑梗死并发症情况并进行总结。结果：发生率为0．91％，且预后较好。结论：急性心肌梗死患者溶栓治疗后出现偏瘫和意识障碍，不但要想到出血性卒中，而且要想到缺血性卒中。应尽早明确诊断，以免贻误病情。     

吻合器痔上黏膜钉合术应用的相关问题

<正>世界首例吻合器痔上黏膜钉合术(procedure forprolapse and hemorrhoids,PPH)由意大利巴勒莫大学外科医生Longo[1]于1993年成功施行并于1998年撰文报道。上海复旦大学附属中山医院姚礼庆教授等[2]于2000年7月从新加坡引进PPH手术,随即该手术在我国广泛开展。目